newtothegame, $75million is a lot of money to commit to a phase 3 trial. This should tell you something about the confidence management has in these phase 2b results. I don't know of any other Australian Biotech that has committed this sort of sum to a phase 3 trial. I think PXS had a placement of around $16million at one stage. Please don't mention CSL or COH.
The buyers, imo have already started to average down. Look at the daily spikes and how they have already started to increase in frequency. Obviously not enough to push the sp up just yet but it will happen. Give it time.
orga
seek expert advice.
AVX Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
